Ibritumomab tiuxetan Antibody
Ibritumomab tiuxetan is a CD20-targeting monoclonal antibody conjugated to a radioisotope via the chelating agent tiuxetan. It is used in radioimmunotherapy research, with applications in studying B-cell malignancies in both in vitro and in vivo experimental models.
Product Specifications
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.8 mg/mL
Purity
98.66% (May vary between batches)
Molecular Weight
148 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog